Skip to main content
. 2011 Dec 22;3(1):e2011069. doi: 10.4084/MJHID.2011.069

Table 3.

Risk of therapy-related myeloid neoplasms in breast cancer patients receiving radiotherapy.

Reference Breast cancer patients (n) Therapy t-MN (n) Cumulative risk (%)

Renella et al, 2006 [33] 2292 Radiotherapy alone 7 1.9
1119 Radiotherapy + chemotherapy 2 1.7

Howard et al, 2007 [4] 99275 Radiotherapy alone 221 0.22 (at 10 y)

Hershman et al, 2007 [40] 2837 Radiotherapy alone 38 1.33

Schaapveld et al, 2008 [5] 31000 Radiotherapy alone 13 1.28 (at 10 y)

Martin et al, 2009 [3] 420076 Radiotherapy +/− chemotherapy 450 0.91 (at 5 y) for range 15–49 years; 1.14 (at 5 y) for range 50–64 years; 1.76 (at 5 y) for >65 years

Zhang et al, 2011 [41] 1779 Radiotherapy alone 7 6.67 (at 4.5 y)
553 Radio- + hormonal therapy
293 Radio- + chemotherapy
25 Radio- + hormonal+chemotherapy
2650 Total